返回 
加入收藏
临床药师参与436例次临床会诊情况分析
x
请在关注微信后，向客服人员索取文件
| 篇名： | 临床药师参与436例次临床会诊情况分析 |
| TITLE： | |
| 摘要： | 目的：评价临床药师参与临床会诊的效果，为临床药师参与临床药学实践提供参考。方法：对2012－2015年郑州市第七人民医院临床药师参与的436例次临床会诊进行统计、分析。结果：2012－2015年，该院临床会诊数量呈增长趋势，申请会诊的科室共23个，排前5位的科室为内分泌科、妇科、神经外科、神经内科和骨科。会诊原因主要为制订抗感染治疗方案（430例次，占97.95％）。会诊意见主要为调整药物品种（303例次，占69.17％）。会诊意见被临床全部采纳405例次（92.89％）。疾病转归为有效307例次，有效率75.80％（307/405）。结论：临床药师通过参与临床会诊，优化药物治疗方案，对提高疗效、保障患者用药安全起着积极作用。临床药师应加强临床医学知识和药学专业知识的学习，通过临床实践总结经验，提高会诊质量。 |
| ABSTRACT： | OBJECTIVE： To evaluate the effects of clinical pharmacist participating in clinical consultation， and to provider reference for clinical pharmacists participating in clinical practice. METHODS： 436 cases/times of clinical consultation in which clinical pharmacists participated in Zhengzhou Seventh People’s Hospital from 2012 to 2015 were analyzed statistically. RESULTS： 2012-2015， the number of clinical consultation in the hospital showed rising tendency； 23 departments applied the consultation， among which top 5 were endocrinology department， gynaecology department， neurosurgery department， neurology department and orthopedics department. The reasons for consultation mainly were the formulation of therapy plan （430 cases/times， accounting for 97.95％）. The consultation suggestions were adjusting drug types （303 cases/times， 69.17％）. Consultation suggestions were adopted completely in 405 cases/times （92.89％）. There were 307 cases/times of effective outcome， with effective rate of 75.80％ （307/405）. CONCLUSIONS： Clinical pharmacists participated in clinical consultation is helpful to optimize therapy plan， play a positive play on the safety of drug use. Clinical pharmacists should further learn clinical medical and pharmaceutical knowledge and summarize the experience of clinical practice to improve the quality of consultation. |
| 期刊： | 2016年第27卷第17期 |
| 作者： | 于丽，赵智峰，李晋宝 |
| AUTHORS： | YU Li，ZHAO Zhifeng，LI Jinbao |
| 关键字： | 临床药师；临床会诊；抗菌药物 |
| KEYWORDS： | Clinical pharmacist； Clinical consultation； Antibiotics |
| 阅读数： | 415 次 |
| 本月下载数： | 11 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
